The 17th International Conference on Malignant Lymphoma (ICML) took place in Lugano, Switzerland, from June 13–17 this year. The conference has been held every 2 to 3 years since its inception in 1981 and has become a significant and influential gathering for lymphoma researchers from around the world, this year hosting 4,761 registered attendees. Here, we provide some highlights of what we felt were the most noteworthy findings, both clinical and pre-clinical, across various lymphoma entities, presented at the 17th ICML.

You do not currently have access to this content.